Home Compliance Novartis Walks Back CEO Comments on FCA Settlement ComplianceNews Novartis Walks Back CEO Comments on FCA Settlement March 30, 2021 49 Share FacebookLinkedinTwitter Taljat David | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Healthcare Fraud: A World Beyond the Anti-Kickback Statute Compliance Relator Alleged Violation of Statutes But Didn’t Adequately Plead False Certification Compliance Second Circuit Defines “Willfulness” Standard Under Anti-Kickback Statute